The study investigates the effectiveness of stage-specific case-management in first episode psychotic disorders, a significant area in mental health care. With a total enrollment of 360 participants, the trial aims to determine whether extended case management (4 years) yields better outcomes compared to shorter interventions (2 years). The findings could influence treatment protocols and healthcare policies in psychosis management, potentially leading to improved patient outcomes and reduced healthcare costs. Given the rising prevalence of psychotic disorders globally, successful outcomes may enhance market opportunities for mental health service providers and inform future product development in psychotropic medications and therapeutic interventions. The competitive landscape includes existing early intervention programs and emerging therapies targeting similar patient populations.